Skip to main content
Year archive

Abliva — 2023 filings

All 23 regulatory filings released by Abliva (ABLI) in 2023, sourced directly from the official regulator.

23 Filings
2023 Period
2023 filings (23)
Filing Released Lang
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-17 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-17 English
Abliva och Owl Therapeutics ingår licens- och samarbetsavtal för NeuroSTAT® vid traumatisk hjärnskada
Capital/Financing Update
2023-11-14 Swedish
Abliva and Owl Therapeutics enter into licensing and collaboration agreement for NeuroSTAT® in Traumatic Brain Injury
Regulatory Filings
2023-11-14 English
Interim / Quarterly Report 2023
Interim / Quarterly Report H1 2023
2023-08-18 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report H1 2023
2023-08-18 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-05-23 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-05-23 English
Beslut vid årsstämma den 5 maj 2023 i Abliva AB (publ)
AGM Information
2023-05-05 Swedish
Resolutions from Annual General Meeting in Abliva AB (publ) on May 5, 2023
AGM Information
2023-05-05 English
Ändring av valberedningens förslag till Ablivas årsstämma 2023
Remuneration Information
2023-05-04 Swedish
Amendment of the Nomination Committee's proposal for Abliva’s Annual General Meeting in 2023
Board/Management Information
2023-05-04 English
Kallelse till årsstämma i Abliva AB (publ)
AGM Information
2023-04-04 Swedish
Notice of Annual General Meeting of Abliva AB (publ)
AGM Information
2023-04-04 English
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-03-31 Swedish
Beslut vid extra bolagsstämma i Abliva AB (publ)
AGM Information
2023-03-08 Swedish
Resolutions at the Extraordinary General Meeting in Abliva AB (publ)
AGM Information
2023-03-08 English
Interim / Quarterly Report 2022
Interim / Quarterly Report FY 2022
2023-02-24 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report FY 2022
2023-02-24 English
Kallelse till extra bolagsstämma i Abliva AB (publ)
Proxy Solicitation & Information Statement
2023-02-13 Swedish
Notice of Extraordinary General Meeting of Abliva AB (publ)
Proxy Solicitation & Information Statement
2023-02-13 English
Ablivas valberedning föreslår Edwin Moses som ny styrelseledamot samt tillträdande ny styrelseordförande vid kommande bolagsstämmor
Board/Management Information
2023-02-13 Swedish
Abliva Nomination Committee to propose Edwin Moses as a new Board member and incoming Chair of the Board of Directors at upcoming General Meetings
Board/Management Information
2023-02-13 English